Assenagon Asset Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-187,541
Closed -$5.96M 1017
2019
Q2
$5.96M Buy
187,541
+4,601
+3% +$144K 0.04% 248
2019
Q1
$6.04M Buy
182,940
+124,744
+214% +$3.88M 0.06% 272
2018
Q4
$1.87M Sell
58,196
-45,387
-44% -$1.71M 0.02% 470
2018
Q3
$4.44M Buy
+103,583
New +$4.89M 0.04% 326
2018
Q2
Sell
-47,769
Closed -$1.9M 564
2018
Q1
$1.9M Buy
47,769
+32,568
+214% +$1.21M 0.02% 337
2017
Q4
$509K Buy
+15,201
New +$540K 0.01% 611

Other funds holding PAHC

Assenagon Asset Management's PAHC Position: Q3 2019 in Review

Assenagon Asset Management sold out of Phibro Animal Health (PAHC) in Q3 2019, closing a stake of 187,541 shares — an estimated $5.96M sold.

Assenagon Asset Management first reported a position in PAHC in Q4 2017 and held it in 6 quarters. The position peaked at $6.04M in Q1 2019. 153 funds tracked by Wall St. Rank hold PAHC as of Q3 2019.

  • Assenagon Asset Management reported no remaining Phibro Animal Health position as of Q3 2019 after selling out during the quarter.
  • Assenagon Asset Management sold 187,541 Phibro Animal Health shares in Q3 2019, an estimated $5.96M.
  • Assenagon Asset Management first reported a position in Phibro Animal Health in Q4 2017 and held it in 6 quarters.
  • Assenagon Asset Management's Phibro Animal Health position peaked at $6.04M in Q1 2019.
  • 153 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2019.

Based on Assenagon Asset Management's 13F filing for Q3 2019, filed 16 Oct 2019.